O objetivo deste estudo foi avaliar a capacidade de gestão do Componente Especializado da Assistência Farmacêutica (CEAF) no Estado de São Paulo (ESP), sob os aspectos: organizacional, operacional e sustentabilidade. O desenho do estudo foi uma investigação avaliativa, com adaptação de um modelo teórico e protocolo de indicadores desenvolvido para aplicação em âmbito nacional, e validado (Grupo Nominal e Comitê Tradicional) para a aplicação na realidade do ESP. A coleta de dados, em 35 unidades, foi realizada em 2017 e 2018 e contemplou todas as áreas que participam da gestão/execução do CEAF do estado, em seu âmbito central e regional. A avaliação da capacidade de gestão foi fundamentada na análise crítica dos resultados obtidos, analisando suas fragilidades e as potencialidades. Verificou-se que a capacidade de gestão foi positiva na dimensão operacional, com desafios concentrados nas demais dimensões. Os resultados demonstraram maiores investimentos e desenvolvimento em aspectos técnicos da assistência farmacêutica (por ex. aspectos logísticos, financiamento e acessibilidade), mas deficitárias em relação a aspectos como: monitoramento de resultados clínicos, regulamentação, infraestrutura e comunicação com os atores envolvidos. Este estudo traz subsídios para a qualificação da gestão e acesso aos medicamentos de alto preço no SUS, ao fornecer informações relevantes para a tomada de decisão.
Palavras-chave:
Avaliação em saúde; Gestão em saúde; Assistência Farmacêutica; Política Nacional de Assistência Farmacêutica; Medicamentos do Componente Especializado da Assistência Farmacêutica.
Abstract:
The aim of this study was to evaluate the Specialized Component of Pharmaceutical Assistance (SCPA) management capacity in the State of São Paulo (SSS), under the organizational, operational and sustainability aspects. The study design was an evaluative investigation, with adaptation of a theoretical model and protocol of indicators developed for application at the national level and validated (Nominal Group and Traditional Committee) for application in the reality of SSS. The data collection in the 35 SCPA units was carried out in 2017 and 2018, and covered all technical areas that participate in the management / execution of the SCPA, in its central and regional scope. The assessment of management capacity was based on a critical analysis of the results obtained, analyzing their weaknesses and potentialities. After collecting35 SCPA units, it was found that the management capacity was positive in the operational dimension with challenges concentrated in the other dimensions. The results showed greater investments and development in technical aspects of pharmaceutical assistance (promoting the availability of drugs) but lacking in relation to the monitoring of clinical results, infrastructure, regulation and communication with the actors involved. This study provides support for the qualification of management and access to high-cost drugs in SUS, by providing relevant information for decision-making.
Keywords:
Health Services Research; Population Health Management; Pharmaceutical Services; High-Cost drugs.
The aim of this study was to evaluate the Specialized Component of Pharmaceutical Assistance (SCPA) management capacity in the State of São Paulo (SSS), under the organizational, operational and sustainability aspects. The study design was an evaluative investigation, with adaptation of a theoretical model and protocol of indicators developed for application at the national level and validated (Nominal Group and Traditional Committee) for application in the reality of SSS. The data collection in the 35 SCPA units was carried out in 2017 and 2018, and covered all technical areas that participate in the management / execution of the SCPA, in its central and regional scope. The assessment of management capacity was based on a critical analysis of the results obtained, analyzing their weaknesses and potentialities. After collecting35 SCPA units, it was found that the management capacity was positive in the operational dimension with challenges concentrated in the other dimensions. The results showed greater investments and development in technical aspects of pharmaceutical assistance (promoting the availability of drugs) but lacking in relation to the monitoring of clinical results, infrastructure, regulation and communication with the actors involved. This study provides support for the qualification of management and access to high-cost drugs in SUS, by providing relevant information for decision-making.
Palavras-chave (keywords):
Health Services Research; Population Health Management; Pharmaceutical Services; High-Cost drugs.
Fatel, K. de O., Rover, M. R. M., Mendes, S. J., Leite, S. N., Storpirits, S.. Desafios na gestão de medicamentos de alto preço no SUS: avaliação da Assistência Farmacêutica em São Paulo. Cien Saude Colet [periódico na internet] (2021/mai). [Citado em 22/12/2024].
Está disponível em: http://cienciaesaudecoletiva.com.br/artigos/desafios-na-gestao-de-medicamentos-de-alto-preco-no-sus-avaliacao-da-assistencia-farmaceutica-em-sao-paulo/18064?id=18064&id=18064
